Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03362515 · ClinicalTrials.gov registry record · Phase 2
Treatment of Post-Operative Sinonasal Polyposis With Topical Furosemide
A Phase 2 study, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT03362515 is a Phase 2 study that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 18 participants.
The verdict
NCT03362515, a Phase 2 study, was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
Prior studies have suggested that topical furosemide may reduce the recurrence of sinonasal polyposis following sinus surgery. This project aims to further investigate that claim through a blinded randomized controlled clinical trial following patients who undergo functional sinus surgery for chronic rhinosinusitis with sinonasal polyposis by randomly assigning participants to receive topical furosemide versus placebo nasal spray for 2 months post operatively. Outcomes would be compared at 6 months through endoscopic grading scores using Lund Kennedy and Meltzer scores as well as Sino-Nasal Outcome Test (SNOT-22) scores to measure the rate and degree of recurrence and impact on symptoms in the treatment group versus placebo.
Interventions
- DRUG Placebo
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2022-04-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03362515
The ClinicalTrials.gov registry entry for NCT03362515 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03362515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03362515 about?
NCT03362515 is a clinical study titled "Treatment of Post-Operative Sinonasal Polyposis With Topical Furosemide". Prior studies have suggested that topical furosemide may reduce the recurrence of sinonasal polyposis following sinus surgery. This project aims to further investigate that claim through a blinded randomized controlled clinical trial following patients who undergo functional sinus surgery for chroni...
What is the current status of trial NCT03362515?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2017-12-01. Estimated completion is 2022-04-14.
What interventions are being tested in trial NCT03362515?
The interventions under investigation include: Placebo (DRUG), Furosemide (DRUG).
Who is sponsoring clinical trial NCT03362515?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.